Towards controlled drug release in the liver

Hepatology

Volumn 32, Issue 6, 2000, Pages 1401-1402

  Poelstra, Klaas ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOGLYCOPROTEIN; BENZYLOXYCARBONYLASPARTIC ACID; CASPASE INHIBITOR; DRUG CARRIER; GALACTOSE; NANOPARTICLE; UNCLASSIFIED DRUG;

APOPTOSIS; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; EDITORIAL; ENDOCYTOSIS; ENZYME ACTIVATION; HUMAN; IMMUNOGENICITY; LIVER; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

EID: 0033661476     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.20843     Document Type: Article

References (15)

1. The role of surface carbohydrates in the hepatic recognition and transport of circulation glycoproteins
2. Targeting of drugs to the liver
3. Targeted delivery of oligodeoxynucleotides to parenchymal liver cells in vivo
4. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon
5. Targeted gene transfer to sinusoidal endothelial cells and expression in vivo
6. Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells
7. Renal specific delivery of sulfamethoxazole in the rat by coupling to the low molecular weight protein lysozyme via an acid-sensitive linker
8. Drug delivery to the kidneys and the bladder with the low molecular weight protein lysozyme
9. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature
10. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells
11. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor
12. Dexamethasone coupled to albumin is selectively taken up by rat nonparenchymal liver cells and attenuates LPS-induced activation of hepatic cells
13. Hepatocyte-directed gene delivery by receptor-mediated endocytosis
14. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines
15. Concanavalin A hepatotoxicity in mice: Tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation